We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
-0.95%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$10.9B
AUM Growth
+$1.47B
(+16%)
Cap. Flow
+$1.54B
Cap. Flow
% of AUM
14.16%
Top 10 Holdings %
Top 10 Hldgs %
12.66%
Holding
527
New
158
Increased
123
Reduced
88
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$163M |
| 2 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$132M |
| 3 |
AGN
Allergan plc
AGN
|
+$129M |
| 4 |
Devon Energy
DVN
|
+$117M |
| 5 |
EA
Electronic Arts
EA
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$93.6M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$89.6M |
| 3 |
Xerox
XRX
|
+$87.3M |
| 4 |
Zoetis
ZTS
|
+$82M |
| 5 |
Citizens Financial Group
CFG
|
+$75.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.1% |
| 2 | Healthcare | 14.81% |
| 3 | Industrials | 13.15% |
| 4 | Financials | 12% |
| 5 | Consumer Discretionary | 9.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Hormel Foods
HRL
$13.8B
| $8.72M | 0.08% |
+201,727
| New | +$8.41M |
|
252
Radian Group
RDN
$4.93B
| $8.41M | 0.08% |
+677,964
| New | +$7.69M |
|
253
Prudential Financial
PRU
$41.8B
| $8.24M | 0.08% |
+114,119
| New | +$7.96M |
|
|
GG
254
DELISTED
Goldcorp Inc
GG
| $8.11M | 0.07% |
+499,531
| New | +$6.94M |
|
|
LM
255
DELISTED
Legg Mason, Inc.
LM
| $7.97M | 0.07% |
+229,694
| New | +$7.2M |
|
|
OXFD
256
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $7.94M | 0.07% |
801,101
+10,235
| +1% | +$105K |
|
257
Amdocs
DOX
$6.22B
| $7.87M | 0.07% |
130,222
-1,193,530
| -90% | -$66.8M |
|
|
TUP
258
DELISTED
Tupperware Brands Corporation
TUP
| $7.51M | 0.07% |
+129,460
| New | +$6.68M |
|
259
Nasdaq
NDAQ
$52.9B
| $7.4M | 0.07% |
334,281
+1,224
| +0.4% | +$25.2K |
|
|
EACQ
260
CALL
DELISTED
Easterly Acquisition Corp
EACQ
| $7.39M | 0.07% |
+761,707
| New | +$7.34M |
|
261
Heritage Insurance Holdings
HRTG
$991M
| $7.25M | 0.07% |
454,047
-68,966
| -13% | -$1.26M |
|
262
Workiva
WK
$3.54B
| $7.22M | 0.07% |
620,063
+306,114
| +98% | +$4.04M |
|
263
SolarEdge
SEDG
$1.95B
| $7.08M | 0.07% |
281,750
+56,750
| +25% | +$1.48M |
|
264
Travelers Companies
TRV
$80.2B
| $7.01M | 0.06% |
+60,088
| New | +$6.56M |
|
|
PETX
265
DELISTED
Aratana Therapeutics, Inc.
PETX
| $6.9M | 0.06% |
1,250,000
+564,448
| +82% | +$2.12M |
|
|
KNGT
266
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
| $6.87M | 0.06% |
+262,641
| New | +$6.87M |
|
267
First Industrial Realty Trust
FR
$8.44B
| $6.82M | 0.06% |
+300,000
| New | +$6.32M |
|
268
Stanley Black & Decker
SWK
$15.7B
| $6.78M | 0.06% |
+64,466
| New | +$6.26M |
|
|
SWFT
269
DELISTED
Swift Transportation Company
SWFT
| $6.39M | 0.06% |
+342,844
| New | +$5.56M |
|
|
CMBT
270
CMB.TECH NV
CMBT
$4.73B
| $6.14M | 0.06% |
600,000
+122,845
| +26% | +$1.33M |
|
271
Biogen
BIIB
$30.7B
| $6.09M | 0.06% |
23,381
+17,546
| +301% | +$4.63M |
|
272
Zevra Therapeutics
ZVRA
$686M
| $6.02M | 0.06% |
25,931
-2,096
| -7% | -$508K |
|
|
NEWR
273
DELISTED
New Relic, Inc.
NEWR
| $5.86M | 0.05% |
+224,700
| New | +$6.21M |
|
274
Virtu Financial
VIRT
$4.93B
| $5.64M | 0.05% |
+255,300
| New | +$5.65M |
|
|
RAS
275
DELISTED
RAIT Financial Trust
RAS
| $5.6M | 0.05% |
1,783,938
-1,077,709
| -38% | -$2.76M |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q1 2016 Portfolio in Review
As of Q1 2016, Alyeska Investment Group held 527 positions worth $10.9B, up 16% from $9.41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Alyeska Investment Group deployed $1.54B of net new capital in Q1 2016, opening 158 new positions and adding to 123 existing holdings. Its largest new stake was Bausch Health: 2,200,000 shares worth $57.9M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Amdocs, an estimated $66.8M trimmed.
- Alyeska Investment Group's largest Q1 2016 buy was Bausch Health: 2,200,000 shares worth $57.9M.
- Alyeska Investment Group added most to Devon Energy in Q1 2016, an estimated $117M increase.
- Alyeska Investment Group's biggest Q1 2016 reduction was Amdocs, cutting an estimated $66.8M.
- Alyeska Investment Group fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $93.6M.
- Alyeska Investment Group's ten largest holdings make up 13% of its $10.9B portfolio in Q1 2016.
- Alyeska Investment Group opened 158 new positions and closed 149 in Q1 2016.
- Alyeska Investment Group's portfolio value rose 16% quarter-over-quarter to $10.9B.
Based on Alyeska Investment Group's 13F filing for Q1 2016, filed 16 May 2016.